Schlieren, Switzerland
Oncobit AG, with its slogan "Enabling personalized cancer care," is a promising player in the medtech space, operating at the intersection of Biotechnology and Health Care. Founded in 2018 as a UZH Spin-off, the company is based in Switzerland. Its core mission involves developing cancer-specific genomic fingerprinting and personalized monitoring tests to enhance therapy decision support for personalized cancer care.
The company gained traction by attracting a Fr.150.00K Seed Round investment on 21 January 2022, with backing from Venture Kick. This financial boost underscores confidence in Oncobit's potential to innovate cancer treatment personalization, leveraging cutting-edge genomic methodologies. As the demand for individualized healthcare solutions grows, Oncobit's strategic focus positions it as a venture worth watching for potential investors eyeing advancements in oncology and personalized medicine.
